QuantumCyte Overview
- Founded
- 2012
- Status
- Private
- Employees
- 9
- Latest Deal Type
- Later Stage VC
- Investors
- 3
QuantumCyte General Information
Description
Developer of automated microdissection designed to improve cancer outcomes. The company's microdissection has developed a unique approach for the isolation and interrogation of individual cancer cells, enabling healthcare providers to carry out single-cell analysis for predicting drug efficacy.
Contact Information
Website
www.quantumcyte.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Drug Discovery
Primary Office
- 428 Oakmead Parkway
- Sunnyvale, CA 94038
- United States
+1 (408) 000-0000
QuantumCyte Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 29-Jun-2021 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 03-May-2017 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 01-Jan-2017 | Completed | Generating Revenue |
QuantumCyte Patents
QuantumCyte Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3092482-A1 | Methods, compositions, and devices for isolation and expression analysis of regions of interest from a tissue | Pending | 02-Mar-2018 | 0000000000 | |
| JP-2021515900-A | Methods, compositions, and devices for isolation and expression analysis of areas of interest from tissues | Pending | 02-Mar-2018 | 0000000000 | |
| AU-2019228081-A1 | Methods, compositions, and devices for isolation and expression analysis of regions of interest from a tissue | Pending | 02-Mar-2018 | 0000000000 | |
| US-20210222229-A1 | Methods, compositions, and devices for isolation and expression analysis of regions of interest from a tissue | Pending | 02-Mar-2018 | 0000000000 | |
| EP-3759213-A1 | Methods, compositions, and devices for isolation and expression analysis of regions of interest from a tissue | Pending | 02-Mar-2018 | C12Q1/6806 |
QuantumCyte Executive Team (4)
QuantumCyte Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialQuantumCyte Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Bayes Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| IndieBio | Accelerator/Incubator | 000 0000 | 000000 0 | ||
| SOSV | Venture Capital | Minority | 000 0000 | 000000 0 |